Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
72-week data of atacicept in IgAN accepted as a best-ranked abstract
Stay updated with breaking news from Inducing Ligand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
72-week data of atacicept in IgAN accepted as a best-ranked abstract
BRISBANE, Calif., Feb. 28, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with...
BRISBANE, Calif., Feb. 02, 2024 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with...
BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients
BRISBANE, Calif., Dec. 27, 2023 -- Vera Therapeutics, Inc. , a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with...